| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.9 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.021 | 0.9 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |